China GMP rules to spur consolidation; Boehringer sees profits drop by half;

 @FiercePharma: Analysts: Expect more hostile bids in pharma. Story | Follow @FiercePharma

> China's new rules on good manufacturing practices are likely to drive consolidation among the country's 5,000-plus pharmaceutical companies, especially the smaller firms, according to legal company Bird & Bird. News

> Boehringer Ingelheim saw net income slump by half in 2010 as cheaper generic copies of some of its best-selling pharmaceuticals came to market. Story

> Sanofi-Aventis has created the third largest generics company in Europe after re-branding its generic operations under the name Zentiva. Item

> AstraZeneca plans to invest 80 billion won ($73.7 million) in South Korea over the next five years to step up cooperation in the country's medical sector. Report

> Shares of Questcor Pharmaceuticals shot up in after-hours trading following the news of its higher-than-expected first-quarter sales forecast. Article

> Mylan Pharmaceuticals has won final FDA approval for its generic version of the Pfizer eye drop Xalatan. News

> Eli Lilly announced the availability of Axiron for testosterone deficiency in pharmacies across the U.S. Report

> BioMarin Pharmaceutical will not seek full rights to Aldurazyme, a drug marketed by partner Genzyme to treat a rare metabolic disease, following Monday's $20 billion acquisition of Genzyme by Sanofi-Aventis. Story

Biotech News

 @FierceBiotech: 10 promising late-stage cancer drugs. Item | Follow @FierceBiotech 

 @JohnCFierce: Bavarian Nordic is raising $123M to finish development of Prostvac for prostate cancer. Story | Follow @JohnCFierce

> Blockbuster antibodies face a unique set of challenges. News

> VCs: Chill sets in on biotech as social networking gets hot. Article 

> FDA panel readies pivotal review of Optimer's fidaxomicin. Report

> Bayer faces setback as Xarelto data highlights increased bleeding risk. Story

> Genzyme touts positive LDL data from mipomersen Ph3. News 

Biotech Research News

> Coming soon: 3D adult stem cells, no glasses required. Article

> Nanoparticles provide protection against nickel allergies. News 

> Israeli biotech Pluristem uses stem cells from placentas. Item

> Gene-patent courtroom drama plays out in Washington. Story 

> Alzheimer's researchers have five new genes to ponder. Report 

> Former football player now studies athletes' genes. Story

Manufacturing News

> DNA links Lilly, GSK warehouse thefts. Article 

> PAT, QbD spur continuous processing. News 

> Merck, Roche add voice to pick operations. Item 

> McNeil consent decree quarantine helps J&J's bottom line. Report

> Roche, Catalent suffer warehouse fires. News

> India marks its fifth $1B drugmaker. Story

And Finally... A new hydration method for preventing kidney damage among patients who receive contrast agents during heart procedures was deemed more effective than the conventional way. Report

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.